Gilead Sciences (NQ:GILD)Price and VolumeDetailed Quote
Top NewsMore News
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH ↗
October 10, 2026
Via The Motley Fool
Topics
ETFs
Performance
52-Week Range
3.9% below 52-week high
151.17
114.0252W Low
157.2952W High
1 Week
0.2% below 1-week high
142.601W Low
151.441W High
Gilead Sciences (GILD) traded between $114.02 and $157.29 over the past 52 weeks and last traded at $151.17, 3.9% below its 52-week high. Over the past week it ranged between $142.60 and $151.44.
Past 12 Months
+4.5%
+4.4%
+15.0%
+8.7%
+24.3%
+29.0%
1W
+$6.54
1M
+$6.36
3M
+$19.77
6M
+$12.14
YTD
+$29.57
1Y
+$33.99
GILD was +29.0% over the past year, +8.7% over six months, +24.3% year to date, +4.5% in the last week.
12 Months vs Market
GILD
DIA
SPY
QQQ
IWM
Over the past 12 months GILD returned +29.0% versus DIA (Dow) +13.5%, SPY (S&P 500) +19.2%, QQQ (Nasdaq 100) +27.4% and IWM (Russell 2000) +17.3%.
Volume & Liquidity
0.97× 3-mo avg
Today 5,802,198
3-mo avg 6.0M
1W
1M
3M
6M
YTD
1Y
GILD most recently traded 5,802,198 shares against a 3-month average daily volume of 6.0M. More NewsRead More
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma ↗
October 10, 2026
Via The Motley Fool
Topics
ETFs
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD)
October 07, 2026
Via StockStory
Topics
Artificial Intelligence
Via MarketBeat
Topics
Artificial Intelligence
Better Healthcare ETF: Vanguard's Broad VHT vs. the iShares Biotechnology-Focused IBB ↗
October 05, 2026
Via The Motley Fool
Topics
ETFs
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP ↗
October 02, 2026
Via The Motley Fool
Topics
ETFs
Better Healthcare ETF: iShares Biotechnology-Focused IBB vs. Simplify's Broad PINK ↗
September 25, 2026
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? ↗
September 24, 2026
Via The Motley Fool
Topics
ETFs
Via The Motley Fool
Topics
ETFs
1 Cash-Producing Stock on Our Buy List and 2 We Find Risky
September 22, 2026
Via StockStory
Via MarketBeat
Via MarketBeat
Topics
Intellectual Property
PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors? ↗
September 15, 2026
Via The Motley Fool
Topics
ETFs
Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth ↗
September 10, 2026
Via MarketBeat
Via MarketBeat
1 S&P 500 Stock on Our Buy List and 2 Facing Challenges
September 09, 2026
Via StockStory
Topics
Stocks
Frequently Asked QuestionsIs Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 151.17
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 10/09/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 189.54B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 190B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>